Business · 28/02/2001

FDA Announces Approval of Postmarketing Study Collection

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to postmarketing studies for approved human drugs and licensed biological products, as required by the Paperwork Reduction Act of 1995.